Purchase Order HHSD2002016M88895P
Award Date 1/14/16
Potential Completion Date 1/13/17
Potential Value $84K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for $84,000.00. The contract is for a service plan and has no set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) DNA/RNA sequencing technology. This contract award is likely part of Pacific Biosciences' broader work providing specialized sequencing...
- This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms, associated reagents, and support services. The $84,000.00 purchase order was issued by the Centers for Disease Control and Prevention (CDC) and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology. The company has...
- This federal contract award to Pacific Biosciences of California, Inc. is for DNA sequencer maintenance services. The $84,000.00 firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania, a civilian agency. The contract has an ultimate completion date of January 13, 2019 and was awarded on January 14, 2018. Pacific Biosciences, a for-profit manufacturer, was selected without a set-aside designation, indicating they are the...
- This contract award is to Pacific Biosciences of California, Inc., a for-profit manufacturer, for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms and associated consumables to the Centers for Disease Control and Prevention (CDC). The $250,000.00 firm-fixed price purchase order has a performance period ending on December 31, 2025. Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to various federal agencies, as evidenced by...
- This federal contract award to Pacific Biosciences of California, Inc. is for the provision of supplies related to SMRT sequencing technology. The $142,982.42 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services and has a period of performance ending on March 31, 2016. Pacific Biosciences is the original equipment manufacturer for their proprietary Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by...
- This is a firm-fixed price contract award to Pacific Biosciences of California, Inc. by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services. The $105,940 contract is for the provision of PacBio reagents, which are used in Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms. These specialized sequencing systems and associated consumables are utilized by various federal civilian and defense agencies to support genomic research...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc., a for-profit manufacturer of specialized scientific equipment, reagents, and services. The $357,500.00 contract is for the provision of Pacific Biosciences' Sequel system, which includes the Sequel DNA/RNA sequencing instrument and associated consumables. The contract has no set-aside designation and is to be performed in...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $193,000.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to upgrade their PacBio Sequel System. This contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. They have fulfilled over $10 million in federal...
- This is a firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc. for $35,000.00. The contract is for the provision of Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and related support services. The contract was awarded on a sole-source basis, as Pacific Biosciences was determined to be the only responsible source capable of meeting NIAID's...
- This is a firm-fixed price purchase order awarded by the Food and Drug Administration (FDA) to Pacific Biosciences of California, Inc. for $24,357.60 to provide PacBio reagents. The contract has a completion date of September 30, 2024 and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are used by federal agencies like the FDA, CDC, USDA, and NIH to support genomic research across...